Vanta Bioscience Limited (VANTABIO.BO)

INR 42.57

(0.0%)

Operating Income Summary of Vanta Bioscience Limited

  • Vanta Bioscience Limited's latest annual operating income in 2023 was -31.83 Million INR , up 37.13% from previous year.
  • Vanta Bioscience Limited's latest quarterly operating income in 2023 FY was -31.83 Million INR , up 37.13% from previous quarter.
  • Vanta Bioscience Limited reported an annual operating income of -50.64 Million INR in 2022, down -335.3% from previous year.
  • Vanta Bioscience Limited reported an annual operating income of 21.52 Million INR in 2021, down -21.68% from previous year.
  • Vanta Bioscience Limited reported a quarterly operating income of 5.19 Million INR for 2023 Q2, up 116.21% from previous quarter.
  • Vanta Bioscience Limited reported a quarterly operating income of -37.03 Million INR for 2023 Q4, down -812.62% from previous quarter.

Annual Operating Income Chart of Vanta Bioscience Limited (2023 - 2017)

Historical Annual Operating Income of Vanta Bioscience Limited (2023 - 2017)

Year Operating Income Operating Income Growth
2023 -31.83 Million INR 37.13%
2022 -50.64 Million INR -335.3%
2021 21.52 Million INR -21.68%
2020 27.47 Million INR -13.6%
2019 31.8 Million INR 5.47%
2018 30.15 Million INR 448.15%
2017 5.5 Million INR 0.0%

Peer Operating Income Comparison of Vanta Bioscience Limited

Name Operating Income Operating Income Difference
Alfavision Overseas (India) Limited 9.28 Million INR 442.971%
Biocon Limited 50.83 Billion INR 100.063%
Blue Jet Healthcare Limited 3.37 Billion INR 100.944%
Concord Biotech Limited 6.26 Billion INR 100.508%
Dishman Carbogen Amcis Limited -13.9 Million INR -129.05%
FERMENTA BIOTECH LIMITED 1.06 Billion INR 102.981%
GENOMIC VALLEY BIOTECH LIMITED 1.27 Million INR 2595.63%
Lyka Labs Limited 29.13 Million INR 209.296%
Panacea Biotec Limited -309.7 Million INR 89.72%
SAMSRITA LABS LIMITED -1.49 Million INR -2026.247%
Servoteach Industries Limited -785.00 INR -4055696.178%
SMS Lifesciences India Limited 359.47 Million INR 108.857%
Supriya Lifescience Limited 1.57 Billion INR 102.026%
Syngene International Limited 14.02 Billion INR 100.227%
TAKE Solutions Limited -213.49 Million INR 85.087%
Titan Biotech Limited 315.89 Million INR 110.079%
Transgene Biotek Limited -7.08 Million INR -349.118%